SNORD116-4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.88178419700125E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.05320246652263E-11 |
Normal-vs-Stage2 |
2.641600E-04 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.63835611743934E-12 |
Stage1-vs-Stage2 |
8.544200E-01 |
Stage1-vs-Stage3 |
4.79639999995118E-06 |
Stage1-vs-Stage4 |
2.398100E-03 |
Stage2-vs-Stage3 |
3.532300E-02 |
Stage2-vs-Stage4 |
5.833600E-02 |
Stage3-vs-Stage4 |
8.622400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6242562850266E-12 |
Normal-vs-AfricanAmerican |
1.80059999999038E-06 |
Normal-vs-Asian |
1.935990E-02 |
Caucasian-vs-AfricanAmerican |
1.674770E-01 |
Caucasian-vs-Asian |
5.424400E-01 |
AfricanAmerican-vs-Asian |
9.622000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.43138842392909E-14 |
Normal-vs-Female |
1.74427139398858E-12 |
Male-vs-Female |
2.549800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.87690000050556E-07 |
Normal-vs-Age(41-60Yrs) |
1.67421632113474E-12 |
Normal-vs-Age(61-80Yrs) |
2.12108108854636E-12 |
Normal-vs-Age(81-100Yrs) |
1.71037999999735E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.744000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.822400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.881200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.005600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.545800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.521400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.123760E-01 |
Normal-vs-Grade 2 |
1.60580004848754E-09 |
Normal-vs-Grade 3 |
1.6251444634463E-12 |
Normal-vs-Grade 4 |
1.62436730732907E-12 |
Grade 1-vs-Grade 2 |
1.578210E-01 |
Grade 1-vs-Grade 3 |
1.092080E-02 |
Grade 1-vs-Grade 4 |
1.65728000000032E-05 |
Grade 2-vs-Grade 3 |
5.344600E-03 |
Grade 2-vs-Grade 4 |
2.36470000247735E-08 |
Grade 3-vs-Grade 4 |
1.157690E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.4830994472278E-10 |
Normal-vs-ccB subtype |
1.62481139653892E-12 |
ccA subtype-vs-ccB subtype |
1.801950E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.83957318664352E-12 |
Normal-vs-N1 |
5.70399999455518E-08 |
N0-vs-N1 |
1.213970E-02 |
|
|